Equities

Regenerative Medical Technology Group Inc

RMTG:PKC

Regenerative Medical Technology Group Inc

Actions
  • Price (USD)0.0315
  • Today's Change0.005 / 17.98%
  • Shares traded12.33k
  • 1 Year change+140.46%
  • Beta1.1581
Data delayed at least 15 minutes, as of Nov 21 2024 14:39 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Regenerative Medical Technology Group Inc., formerly Meso Numismatics, Inc., is a regenerative medicine company. The Company through its subsidiary, Global Stem Cells Group (GSGC), the Company specializes in manufacturing clinical products, cutting edge stem cell research, patient applications, and physical training. It is engaged in regenerative medicine global research, clinical applications, world class products, lab and clinic equipment, and physician training. Its services include certified training courses for physicians, manufacturing and sales of equipment and supplies, research and development of clinical protocols, regenerative medicine clinics for patients, regenerative medicine practitioners’ network, and turnkey stem cell processing center solutions. The Company with ISSCA (International Society for Stem Cell Application) provides comprehensive physician training and certification programs that medical professionals are equipped with the latest advancements and techniques.

  • Revenue in USD (TTM)2.87m
  • Net income in USD-10.15m
  • Incorporated2001
  • Employees1.00
  • Location
    Regenerative Medical Technology Group Inc433 Plaza Real Suite 275BOCA RATON 33432United StatesUSA
  • Phone+1 (702) 483-0318
  • Fax+1 (509) 561-6923
  • Websitehttps://regenmedtechgroup.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Propanc Biopharma Inc0.00-1.87m236.97k1.00---------0.0372-0.03720.00-0.0060.00-------1,495.00-4,082.63---------------2.55--------35.61------
CNBX Pharmaceuticals Inc230.08k-1.21m284.67k2.00------1.24-0.0458-0.04580.0081-0.07890.6201----115,040.00-325.63-73.32---99.8014.96---525.10-3,970.88---1.34------111.900.3497------
Endonovo Therapeutics Inc255.72k-4.40m317.46k0.00------1.24-0.0652-0.06520.0003-0.0720.2256-------388.54-303.26----96.2174.38-1,722.26-5,956.27---1.38----85.15---495.02------
Neximmune Inc0.00-20.62m338.73k6.00--0.4864-----18.59-18.590.000.660.00----0.00-140.56-115.07-224.94-165.07------------0.00------48.25---44.65--
GlobeStar Therapeutics Corp0.00-1.98m348.88k-----------0.0023-0.00230.00-0.00150.00-------38,103.72-4,657.88-------7,790.20---2,834,410.00---21.00---------31.01------
Yield10 Bioscience Inc750.00k-12.70m363.66k29.00------0.4849-135.92-135.921.95-9.710.1697----25,862.07-287.44-91.26---108.09-----1,693.60-2,279.74---------86.67-35.94-6.55--1.84--
LadRx Corp0.00-2.78m364.98k2.00---------5.61-5.610.00-3.540.00----0.00-177.00-58.97---78.44--------------------106.96------
Regenerative Medical Technology Grop Inc2.87m-10.15m394.98k1.00------0.1375-0.8144-0.81440.2303-2.070.5424--76.15---191.67-192.08----68.9560.24-353.35-821.490.0257-0.0755----57.49116.97-76.03--149.35--
Capstone Therapeutics Corp0.00-358.00k504.35k2.00---------6.58-38.120.00-60.700.00-------113.46141.94-199.60173.06-----------2.92--------52.46------
Novelstem International Corp12.00k-3.02m520.38k15.00------43.37-0.0644-0.06440.0003-0.10650.0108--3.20---106.25-----------9,816.08-----4.90----0.00---446.84------
Data as of Nov 21 2024. Currency figures normalised to Regenerative Medical Technology Group Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.